Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia

Bibliographic Details
Main Authors:	Metadilogkul Orapun, Jirathitikal Vichai, Orlovsky Vladimir, Bourinbaiar Aldar, Dmitry Popov
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Retrovirology

Similar Items

Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor
by: Orapun Metadilogkul, et al.
Published: (2009-01-01)

Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study
by: Jirathitikal Vichai, et al.
Published: (2010-02-01)

The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting.
by: Jamie P Morano, et al.
Published: (2013-01-01)

Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019-12-01)

Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
by: Thijs Feuth, et al.
Published: (2013-01-01)

Diversity and Evolution of HIV and HCV
by: Miguel Angel Martinez
Published: (2021-04-01)

Treatment of HCV and HIV coinfection
by: J. Alberto Juárez Navarro
Published: (2006-01-01)

Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
by: Monia Puglia, et al.
Published: (2016-07-01)

Evaluation of Vaccine-Preventable Diseases, HIV and HCV Antibody Levels in Residents
by: Ahmet Ayrancı, et al.
Published: (2019-12-01)

Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines
by: Mina eJohn, et al.
Published: (2014-10-01)

Why vaccine for HIV, HCV and Malaria has failed so far
by: Shuo eLi, et al.
Published: (2015-11-01)

Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals
by: M.S. Carrillo, et al.
Published: (2017-12-01)

Profile of HIV subtypes in HIV/HBV- and HIV/HCV-coinfected patients in Southern Brazil
by: Valéria Miranda Avanzi, et al.

Identifying smoking cessation targets for people living with HIV and HIV-HCV
by: Blake Linthewaite, et al.
Published: (2018-05-01)

HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection.
by: Bahareh Vali, et al.
Published: (2008-01-01)

HIV-HCV coinfection and liver cancer
by: Aluisio Segurado

Immunological aspects of HCV/HIV coinfection
by: Nikolay Dmitrievich Yushchuk, et al.
Published: (2011-11-01)

New drug interactions in HIV and HCV
by: Back David
Published: (2012-05-01)

Glances in Immunology of HIV and HCV Infection
by: Maria Giovanna Quaranta, et al.
Published: (2012-01-01)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
by: Yu Wang, et al.
Published: (2021-09-01)

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.
by: Florence Abravanel, et al.
Published: (2012-01-01)

Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
by: Jean-Jacques Tudesq, et al.
Published: (2017-01-01)

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing.
by: Alvaro Mena, et al.
Published: (2014-01-01)

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection
by: Monica Basso, et al.
Published: (2021-04-01)

ACTIVATION OF BLOOD T-CELLS IN HIV/HCV CO-INFECTED PATIENT
by: Matsiyeuskaya Natallia V., et al.
Published: (2013-01-01)

Activation of blood T-cells in HIV/HCV co-infected patients
by: Matsiyeuskaya Natallia V, et al.
Published: (2013-03-01)

Effect of HCV on lipids profile of HIV patients
by: Mehrnaz Rasoolinejad, et al.
Published: (2012-02-01)

Virological Mechanisms in the Coinfection between HIV and HCV
by: Maria Carla Liberto, et al.
Published: (2015-01-01)

Seroprevalances of HBV, HCV and HIV in Hakkari Province
by: Fikret Tekay
Published: (2006-01-01)

The epidemiology of hepatitis C and HCV-HIV coinfection
by: Mohsen, Abdul Hadi
Published: (2005)

Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.
by: Yuan Dong, et al.
Published: (2014-01-01)

The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination
by: Nabila Seddiki, et al.
Published: (2020-07-01)

Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination
by: Eun-Ju Ko, et al.
Published: (2019-12-01)

Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.
by: Jin Zhao, et al.
Published: (2012-01-01)

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
by: Michelle Spaan, et al.
Published: (2016-01-01)

Liver Damage in Patients with HCV/HIV Coinfection Is Linked to HIV-Related Oxidative Stress
by: Xiangbo Huang, et al.
Published: (2016-01-01)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
by: Anna Turkova, et al.
Published: (2015-07-01)

Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients
by: Isabelle Ravaux, et al.
Published: (2016-05-01)

Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection
by: Anne Searls De Groot, et al.
Published: (2014-10-01)

Metabolic abnormalities and liver stiffness evaluated by Transient Elastography in HIV and HIV/HCV coinfected patients
by: Catarina Magalhães Castelo Branco
Published: (2019)